Loading data
NRGVNYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 203.67 m USD | 46.2 m USD | 341.54 m USD | 145.88 m USD | 0 USD |
| Cost of revenue | 155.68 m USD | 40.01 m USD | 324.01 m USD | 86.58 m USD | 0 USD |
| Gross profit | 47.99 m USD | 6.19 m USD | 17.53 m USD | 59.3 m USD | — |
| Research and development expense | 14.64 m USD | 26 m USD | 37.1 m USD | 42.61 m USD | 7.91 m USD |
| Operating profit | -74.37 m USD | -130 m USD | -106.74 m USD | -63.08 m USD | -29.54 m USD |
| Interest expense | — | — | 35 k USD | 2 k USD | 7 k USD |
| Profit before tax | -95.9 m USD | -135.75 m USD | -98.79 m USD | -77.87 m USD | -31.34 m USD |
| Income tax expense | 7.76 m USD | 67 k USD | -349 k USD | 427 k USD | 1 k USD |
| Net income (reported basis) | -103.6 m USD | -135.75 m USD | -98.4 m USD | -78.3 m USD | -31.34 m USD |
| Net income attributable to common shareholders | -104.47 m USD | -135.75 m USD | -98.44 m USD | -78.3 m USD | -31.34 m USD |
| Basic earnings per share | -0.65 USD/share | -0.91 USD/share | -0.69 USD/share | -0.64 USD/share | -2.45 USD/share |
| Diluted earnings per share | -0.65 USD/share | -0.91 USD/share | -0.69 USD/share | -0.64 USD/share | -2.45 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.